Vilin Bio Med shareholders and shareholding pattern
NSE: VILINBIOPharmaceuticals & Biotechnology
Vilin Bio Med Limited · Face value ₹10 Face value. The nominal value of one share as the company issued it, the unit its share capital is counted in and a dividend can be stated as a percentage of; it has no link to the share price. Face value in the glossary · Listed Jun 2023 · Issue price ₹30
Last close ₹52.05up ₹1.60 (3.17%)
Share price at the NSE close on 30 Oct 2026. Previous close ₹50.45.
30 Oct: open ₹49.95, high ₹52.05, low ₹48.60
52-week range of traded prices to 30 Oct 2026
₹18.95Low, 16 Dec 2025₹60.95High, 9 Sep 2026
- Market capMarket capitalisation. Share price times the number of shares: what the whole company is worth at the day's price. Market capitalisation: how it is worked out
- ₹79 Cr
- P/EPrice to earnings, trailing. Market cap divided by the profit of the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, after the share of the other owners of its subsidiaries: what investors pay for each rupee of a year's profit. Price to earnings, trailing: how it is worked out
- 41.15
- P/BPrice to book. Market cap divided by the net worth that belongs to the company's own shareholders, its assets less everything it owes and less the other owners' share of its subsidiaries, on its latest balance sheet. Price to book: how it is worked out
- 2.80
- Dividend yieldDividend yield. Dividends paid per share in the twelve months to the day, as a percentage of the day's share price.
- Nonein the last 12 months
- ROEReturn on equity. Profit over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, as a percentage of their net worth, the money they have in the business. Net worth is the average of the latest balance sheet and the one a year before it.
- 7.5%
- Debt to equityDebt to equity. Borrowings divided by the whole group's net worth, the other owners of its subsidiaries included: rupees borrowed for each rupee of equity in the business. Lease liabilities are not counted: the results filings do not state them. From the balance sheet at the end of Mar 2026.
- 0.01
- Volume, NSEVolume. Shares traded on the last trading day; delivery is the part buyers kept rather than sold again the same day. Volume in the glossary
- 16,000100.0% delivered
Vilin Bio Med's shareholding pattern for Sep 2026, filed on 18 Oct 2026, with every filing from Sep 2023: who owns its shares by group, its promoters by name and its public holders of 1% or more.
Who owns Vilin Bio Med, filing by filing
Per cent of the company's shares.
Sep 2026 filing
- Promoters56.65%
- Foreign institutions0.13%
- Individuals and others43.22%
Shareholding pattern, per cent
- Promoters
- Foreign institutions
- Individuals and others
| Per cent | Sep 2023 | Mar 2024 | Sep 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | Sep 2026 |
|---|---|---|---|---|---|---|---|---|---|---|
| 64.52% | 64.52% | 64.09% | 63.89% | 63.89% | 63.89% | 65.12% | 59.57% | 56.65% | 56.65% | |
| Indian promoters | 64.52% | 64.52% | 64.09% | 63.89% | 63.89% | 63.89% | 65.12% | 59.57% | 56.65% | 56.65% |
| Public. Every shareholder outside the promoter group, the employee trusts and the shares held against depositary receipts, as the filing totals them. Public in the glossary | 35.48% | 35.48% | 35.91% | 36.11% | 36.11% | 36.11% | 34.88% | 40.43% | 43.35% | 43.35% |
| Shares in issue | 1,39,50,000 | 1,39,50,000 | 1,39,50,000 | 1,39,50,000 | 1,39,50,000 | 1,39,50,000 | 1,39,50,000 | 1,52,50,000 | 1,52,50,000 | 1,52,50,000 |
| Shares locked inShares locked in. Shares the filing reports as barred from sale until a set day, such as promoters' shares after a public issue or shares allotted to an investor directly. Shares locked in in the glossary | 99,50,000 | 99,50,000 | 27,90,551 | 27,90,551 | 27,90,551 | 27,90,551 | 27,90,551 | 36,27,317 | 40,90,551 | 13,00,000 |
| Promoters' shares locked in | 89,99,999 | 89,99,999 | 27,90,551 | 27,90,551 | 27,90,551 | 27,90,551 | 27,90,551 | 23,27,317 | 27,90,551 | – |
A dash is a line the filing did not state.
Vilin Bio Med promoters
Promoters are the founders, families and companies that control the company, as its filings name them. Every member of the promoter group holding shares in the filing for Sep 2026; the largest is SHARAZ SHAIK, 12.01%.Promoter buying and selling
| Holder | ||
|---|---|---|
| SHARAZ SHAIKIndividuals and Hindu undivided families | 12.01% | 18,31,979 |
| SHANKAR REDDY KATIREDDYIndividuals and Hindu undivided families | 11.68% | 17,80,520 |
| PRAVALLIKA VENNAIndividuals and Hindu undivided families | 8.76% | 13,35,400 |
| ALLU RAMAKRISHNA REDDYIndividuals and Hindu undivided families | 7.30% | 11,12,830 |
| JULAKANTI NAGA AVINASH REDDYIndividuals and Hindu undivided families | 5.84% | 8,90,260 |
| KARUNAKAR REDDY KUNDOORIndividuals and Hindu undivided families | 4.38% | 6,67,700 |
| MOHAN RAO ADHIIndividuals and Hindu undivided families | 3.31% | 5,05,130 |
| JWALA VEERAVENKATA PANDURANGA PRANEETHIndividuals and Hindu undivided families | 2.92% | 4,45,130 |
| TANMAYEE REDDY SAMAIndividuals and Hindu undivided families | 0.14% | 21,250 |
| RAMIZA SHAIKIndividuals and Hindu undivided families | 0.13% | 20,000 |
| ANUJ BAJPAIIndividuals and Hindu undivided families | 0.10% | 15,000 |
| SNEH BAJPAIIndividuals and Hindu undivided families | 0.06% | 9,375 |
No promoter shares are reported as pledged.
Largest public holders of Vilin Bio Med, filing by filing
Per cent, on the same shares as the split above.
| Holder | Sep 2023 | Mar 2024 | Sep 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | Sep 2026 |
|---|---|---|---|---|---|---|---|---|---|---|
| ENSPIRE INSTITUTE OF PROFESSIONAL STUDIES LLPCompanies | – | – | – | – | – | – | – | 4.39% | 4.39% | 4.39% |
| AMN VENTURES LLPCompanies | – | – | – | – | – | – | – | 4.13% | 4.13% | 4.13% |
| PERCY HOMI ITALIAResident individuals, over ₹2 lakh at face value | 4.40% | 4.17% | 4.17% | 4.29% | 4.29% | 4.29% | 4.29% | 3.92% | 3.92% | 3.92% |
| KRISHNAResident individuals, over ₹2 lakh at face value | 1.06% | 2.47% | 2.61% | 2.72% | 2.75% | 2.75% | 2.95% | 2.86% | 2.86% | 2.86% |
| CHENUGONIPALLY MAHESHWAR REDDYResident individuals, over ₹2 lakh at face value | – | – | – | – | – | – | – | – | 1.08% | 1.36% |
| BOSCO ARMANDO MENEZESResident individuals, up to ₹2 lakh at face value | – | – | – | – | – | – | – | – | 1.08% | 1.31% |
| SRINIVASA REDDY DEVIREDDYResident individuals, over ₹2 lakh at face value | – | – | – | – | – | – | – | – | 1.87% | – |
| GLASTON MARIO MENEZESResident individuals, up to ₹2 lakh at face value | – | – | – | – | – | – | 1.00% | – | 1.08% | – |
| SUDHANSHU KANDAResident individuals, up to ₹2 lakh at face value | – | – | – | – | – | – | – | 1.05% | – | – |
| KASHINATH SAHUResident individuals, over ₹2 lakh at face value | 1.79% | 1.79% | 1.79% | 1.79% | – | – | – | – | – | – |
| CHAITANYA KIRAN VALLAPUREDDYResident individuals, up to ₹2 lakh at face value | 1.19% | 1.19% | 1.14% | 1.14% | – | – | – | – | – | – |
| RIKHAV SECURITIES LIMITEDOther non-institutions | 1.43% | – | – | – | – | – | – | – | – | – |
A filing names every holder above one per cent, in the company's own words: an insurer's holding can carry one of its funds' names. A dash is a filing that did not name the holder, which includes holding under one per cent.
Who moved in the Sep 2026 filing
Against the Jun 2026 filing. A filing names a public holder only at 1% or more, so a holder no longer named fell under 1% or sold out.
- Individuals and others: SRINIVASA REDDY DEVIREDDY no longer named, from 1.87%; GLASTON MARIO MENEZES no longer named, from 1.08%; CHENUGONIPALLY MAHESHWAR REDDY 1.36%, +0.28 pts; 1 more moved